President and CEO
The benefits of Koppers Zero Harm culture have never proven more important as employees throughout the organization are taking care of each other with great success. Maintaining the health and safety of employees has allowed Koppers to maintain critical business continuity in order to provide essential products and services. To date, approximately 7 percent of global employees tested or self-quarantined for a period of time with less than 1 percent of employees currently under self-quarantine. Currently, all the company's continuing operations are running since the facility in
For
- Sales for RUPS of
$71.5 million increased by$6.0 million , or 9.2 percent, compared to sales of$65.5 million in the prior year month. The sales increase was primarily due to higher volumes of untreated crossties to Class I customers and higher volumes of treated crossties for commercial railroads as well as increased demand for utility poles. - Sales for PC of
$38.0 million decreased by$2.1 million , or 5.2 percent, compared to sales of$40.1 million in the prior year month. The year-over-year decrease was primarily due to the temporary shutdown inNew Zealand and generally lower volumes in overseas markets, partially offset by strong demand in theU.S. andAustralia . - Sales for CMC totaling
$26.3 million decreased by$20.3 million , or 43.6 percent, compared to sales of$46.6 million in the prior year month. The year-over-year decrease was driven by weak markets in all geographies, particularly inEurope . - Capital expenditures for
April 2020 were$3.6 million , compared with$3.1 million inApril 2019 . For the year-to-date period endedApril 30, 2020 , capital expenditures were$14.3 million compared with$14.1 million for the prior year period.
Beginning in 2020, in accordance with generally accepted accounting principles, results of
Pending Divestiture of
In
The KJCC facility, located in Pizhou City in
Since receiving approval from the
Debt and Liquidity
As of
Investor Conference Call and Webcast
Koppers management will conduct a conference call this morning, beginning at
Interested parties may access the live audio broadcast by dialing 1-833-366-1128 in
The conference call will be broadcast live online at: https://services.choruscall.com/links/koppers200520.html. (Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your internet browser's URL address field.)
An audio replay will be available approximately two hours after the completion of the call at 1-877-344-7529 for
About Koppers
Koppers, with corporate headquarters in
For more information, visit us on the Web: www.koppers.com. Questions concerning investor relations should be directed to
Safe Harbor Statement
Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and may include, but are not limited to, statements about sales levels, acquisitions, restructuring, declines in the value of Koppers assets and the effect of any resulting impairment charges, profitability and anticipated expenses and cash outflows. All forward-looking statements involve risks and uncertainties. All statements contained herein that are not clearly historical in nature are forward-looking, and words such as "outlook," "guidance," "forecast," "believe," "anticipate," "expect," "estimate," "may," "will," "should," "continue," "plan," "potential," "intend," "likely," or other similar words or phrases are generally intended to identify forward-looking statements. Any forward-looking statement contained herein, in other press releases, written statements or other documents filed with the
Many of these risks, uncertainties and contingencies are beyond our control, and may cause actual results, performance or achievements to differ materially from anticipated results, performance or achievements. Factors that might affect such forward-looking statements include, among other things, the impact of changes in commodity prices, such as oil and copper, on product margins; general economic and business conditions; the length and extent of economic contraction as a result of the coronavirus (COVID-19) pandemic; disruption in the
BASIS OF PRESENTATION
Beginning in 2020, results of
UNAUDITED SEGMENT INFORMATION |
||||||||||||||||||||
Three Months Ended |
Year Ended |
|||||||||||||||||||
2019 |
2019 |
2019 |
2019 |
2019 |
||||||||||||||||
(Dollars in millions) |
||||||||||||||||||||
Net sales: |
||||||||||||||||||||
RUPS |
$ |
166.1 |
$ |
199.1 |
$ |
198.8 |
$ |
169.5 |
$ |
733.5 |
||||||||||
PC |
99.0 |
120.8 |
123.9 |
104.6 |
448.3 |
|||||||||||||||
CMC |
111.8 |
124.0 |
111.4 |
108.0 |
455.2 |
|||||||||||||||
Total |
$ |
376.9 |
$ |
443.9 |
$ |
434.1 |
$ |
382.1 |
$ |
1,637.0 |
||||||||||
Adjusted EBITDA: |
||||||||||||||||||||
RUPS |
$ |
14.3 |
$ |
18.9 |
$ |
16.9 |
$ |
10.2 |
$ |
60.2 |
||||||||||
PC |
15.5 |
21.0 |
17.8 |
14.4 |
68.6 |
|||||||||||||||
CMC |
11.5 |
23.8 |
22.6 |
15.6 |
73.5 |
|||||||||||||||
Corporate |
(0.5) |
(0.4) |
(0.2) |
(0.4) |
(1.2) |
|||||||||||||||
Total |
$ |
40.8 |
$ |
63.3 |
$ |
57.1 |
$ |
39.8 |
$ |
201.1 |
||||||||||
Adjusted EBITDA %: |
||||||||||||||||||||
RUPS |
8.6 |
% |
9.5 |
% |
8.5 |
% |
6.0 |
% |
8.2 |
% |
||||||||||
PC |
15.7 |
% |
17.4 |
% |
14.4 |
% |
13.8 |
% |
15.3 |
% |
||||||||||
CMC |
10.3 |
% |
19.2 |
% |
20.3 |
% |
14.4 |
% |
16.1 |
% |
||||||||||
Total |
10.8 |
% |
14.3 |
% |
13.2 |
% |
10.4 |
% |
12.3 |
% |
UNAUDITED RECONCILIATION OF OPERATING PROFIT TO EBITDA AND ADJUSTED EBITDA |
||||||||||||||||||||
(In millions) |
||||||||||||||||||||
Three Months Ended March 31, 2019 |
||||||||||||||||||||
Corporate |
||||||||||||||||||||
RUPS |
PC |
CMC |
Unallocated |
Consolidated |
||||||||||||||||
Operating profit (loss) |
$ |
8.7 |
$ |
12.8 |
$ |
3.3 |
$ |
(0.5) |
$ |
24.3 |
||||||||||
Other income (loss) |
(0.2) |
0.9 |
(0.1) |
0.0 |
0.6 |
|||||||||||||||
Depreciation and amortization |
4.8 |
4.9 |
3.9 |
0.0 |
13.6 |
|||||||||||||||
Depreciation in impairment and restructuring charges |
0.0 |
0.0 |
0.2 |
0.0 |
0.2 |
|||||||||||||||
EBITDA |
$ |
13.3 |
$ |
18.6 |
$ |
7.3 |
$ |
(0.5) |
$ |
38.7 |
||||||||||
Unusual items impacting EBITDA: |
||||||||||||||||||||
CMC restructuring |
0.0 |
0.0 |
4.2 |
0.0 |
4.2 |
|||||||||||||||
Non-cash LIFO expense |
1.0 |
0.0 |
0.0 |
0.0 |
1.0 |
|||||||||||||||
Mark-to-market commodity hedging |
0.0 |
(3.1) |
0.0 |
0.0 |
(3.1) |
|||||||||||||||
Adjusted EBITDA |
$ |
14.3 |
$ |
15.5 |
$ |
11.5 |
$ |
(0.5) |
$ |
40.8 |
||||||||||
Adj. EBITDA % of Consolidated Adj. EBITDA (excluding |
34.6 |
% |
37.5 |
% |
27.8 |
% |
UNAUDITED RECONCILIATION OF OPERATING PROFIT TO EBITDA AND ADJUSTED EBITDA |
||||||||||||||||||||
(In millions) |
||||||||||||||||||||
Three Months Ended |
||||||||||||||||||||
Corporate |
||||||||||||||||||||
RUPS |
PC |
CMC |
Unallocated |
Consolidated |
||||||||||||||||
Operating profit (loss) |
$ |
11.8 |
$ |
14.0 |
$ |
13.0 |
$ |
(0.6) |
$ |
38.2 |
||||||||||
Other income (loss) |
(0.3) |
0.5 |
(0.4) |
0.2 |
0.0 |
|||||||||||||||
Depreciation and amortization |
4.8 |
4.6 |
3.1 |
0.0 |
12.5 |
|||||||||||||||
Depreciation in impairment and restructuring charges |
0.0 |
0.0 |
0.9 |
0.0 |
0.9 |
|||||||||||||||
EBITDA |
$ |
16.3 |
$ |
19.1 |
$ |
16.6 |
$ |
(0.4) |
$ |
51.6 |
||||||||||
Unusual items impacting EBITDA: |
||||||||||||||||||||
CMC restructuring |
0.0 |
0.0 |
6.9 |
0.0 |
6.9 |
|||||||||||||||
Non-cash LIFO expense |
2.4 |
0.0 |
0.3 |
0.0 |
2.7 |
|||||||||||||||
Mark-to-market commodity hedging |
0.0 |
1.9 |
0.0 |
0.0 |
1.9 |
|||||||||||||||
RUPS treating plant closures |
0.2 |
0.0 |
0.0 |
0.0 |
0.2 |
|||||||||||||||
Adjusted EBITDA |
$ |
18.9 |
$ |
21.0 |
$ |
23.8 |
$ |
(0.4) |
$ |
63.3 |
||||||||||
Adj. EBITDA % of Consolidated Adj. EBITDA (excluding |
29.7 |
% |
33.0 |
% |
37.4 |
% |
UNAUDITED RECONCILIATION OF OPERATING PROFIT TO EBITDA AND ADJUSTED EBITDA |
||||||||||||||||||||
(In millions) |
||||||||||||||||||||
Three Months Ended |
||||||||||||||||||||
Corporate |
||||||||||||||||||||
RUPS |
PC |
CMC |
Unallocated |
Consolidated |
||||||||||||||||
Operating profit (loss) |
$ |
11.3 |
$ |
11.7 |
$ |
14.0 |
$ |
(0.5) |
$ |
36.5 |
||||||||||
Other income (loss) |
(0.6) |
0.3 |
0.0 |
0.3 |
0.0 |
|||||||||||||||
Depreciation and amortization |
4.8 |
4.5 |
4.0 |
0.0 |
13.3 |
|||||||||||||||
Depreciation in impairment and restructuring charges |
0.0 |
0.0 |
1.3 |
0.0 |
1.3 |
|||||||||||||||
EBITDA |
$ |
15.5 |
$ |
16.5 |
$ |
19.3 |
$ |
(0.2) |
$ |
51.1 |
||||||||||
Unusual items impacting EBITDA: |
||||||||||||||||||||
CMC restructuring |
0.0 |
0.0 |
3.3 |
0.0 |
3.3 |
|||||||||||||||
Mark-to-market commodity hedging |
0.0 |
1.3 |
0.0 |
0.0 |
1.3 |
|||||||||||||||
Non-cash LIFO expense |
1.2 |
0.0 |
0.0 |
0.0 |
1.2 |
|||||||||||||||
RUPS treating plant closures |
0.2 |
0.0 |
0.0 |
0.0 |
0.2 |
|||||||||||||||
Adjusted EBITDA |
$ |
16.9 |
$ |
17.8 |
$ |
22.6 |
$ |
(0.2) |
$ |
57.1 |
||||||||||
Adj. EBITDA % of Consolidated Adj. EBITDA (excluding |
29.5 |
% |
31.1 |
% |
39.4 |
% |
UNAUDITED RECONCILIATION OF OPERATING PROFIT TO EBITDA AND ADJUSTED EBITDA |
||||||||||||||||||||
(In millions) |
||||||||||||||||||||
Three Months Ended |
||||||||||||||||||||
Corporate |
||||||||||||||||||||
RUPS |
PC |
CMC |
Unallocated |
Consolidated |
||||||||||||||||
Operating profit (loss) |
$ |
4.0 |
$ |
13.6 |
$ |
8.9 |
$ |
(0.5) |
$ |
26.0 |
||||||||||
Other income (loss) |
0.0 |
0.4 |
(0.5) |
0.2 |
0.1 |
|||||||||||||||
Depreciation and amortization |
5.0 |
4.3 |
2.5 |
0.0 |
11.8 |
|||||||||||||||
Depreciation in impairment and restructuring charges |
0.0 |
0.0 |
0.8 |
0.0 |
0.8 |
|||||||||||||||
EBITDA |
$ |
9.0 |
$ |
18.3 |
$ |
11.7 |
$ |
(0.3) |
$ |
38.7 |
||||||||||
Unusual items impacting EBITDA: |
||||||||||||||||||||
CMC restructuring |
0.0 |
0.0 |
5.4 |
0.0 |
5.4 |
|||||||||||||||
Non-cash LIFO (benefit) expense |
1.1 |
0.0 |
(1.5) |
0.0 |
(0.4) |
|||||||||||||||
Mark-to-market commodity hedging |
0.0 |
(4.0) |
0.0 |
0.0 |
(4.0) |
|||||||||||||||
Adjusted EBITDA |
$ |
10.1 |
$ |
14.3 |
$ |
15.6 |
$ |
(0.3) |
$ |
39.7 |
||||||||||
Adj. EBITDA % of Consolidated Adj. EBITDA (excluding |
25.3 |
% |
35.8 |
% |
39.0 |
% |
UNAUDITED RECONCILIATION OF OPERATING PROFIT TO EBITDA AND ADJUSTED EBITDA |
||||||||||||||||||||
(In millions) |
||||||||||||||||||||
Year Ended |
||||||||||||||||||||
Corporate |
||||||||||||||||||||
RUPS |
PC |
CMC |
Unallocated |
Consolidated |
||||||||||||||||
Operating profit (loss) |
$ |
35.8 |
$ |
52.1 |
$ |
39.2 |
$ |
(2.1) |
$ |
125.0 |
||||||||||
Other income (loss) |
(1.1) |
2.2 |
(1.4) |
0.9 |
0.6 |
|||||||||||||||
Depreciation and amortization |
19.4 |
18.3 |
13.5 |
0.0 |
51.2 |
|||||||||||||||
Depreciation in impairment and restructuring charges |
0.0 |
0.0 |
3.4 |
0.0 |
3.4 |
|||||||||||||||
EBITDA |
$ |
54.1 |
$ |
72.6 |
$ |
54.7 |
$ |
(1.2) |
$ |
180.2 |
||||||||||
Unusual items impacting EBITDA: |
||||||||||||||||||||
CMC restructuring |
0.0 |
0.0 |
19.8 |
0.0 |
19.8 |
|||||||||||||||
Non-cash LIFO expense (benefit) |
5.7 |
0.0 |
(1.2) |
0.0 |
4.5 |
|||||||||||||||
RUPS treating plant closures |
0.5 |
0.0 |
0.0 |
0.0 |
0.5 |
|||||||||||||||
Mark-to-market commodity hedging |
0.0 |
(3.9) |
0.0 |
0.0 |
(3.9) |
|||||||||||||||
Adjusted EBITDA |
$ |
60.3 |
$ |
68.7 |
$ |
73.3 |
$ |
(1.2) |
$ |
201.1 |
||||||||||
Adj. EBITDA % of Consolidated Adj. EBITDA (excluding |
29.8 |
% |
34.0 |
% |
36.2 |
% |
UNAUDITED RECONCILIATION OF NET INCOME TO EBITDA AND ADJUSTED EBITDA |
||||||||||||||||||||
(In millions) |
||||||||||||||||||||
Three Months Ended |
Year Ended |
|||||||||||||||||||
2019 |
2019 |
2019 |
2019 |
2019 |
||||||||||||||||
Net income |
$ |
12.5 |
$ |
14.4 |
$ |
20.4 |
$ |
20.1 |
$ |
67.4 |
||||||||||
Interest expense |
16.2 |
15.9 |
15.5 |
14.3 |
61.9 |
|||||||||||||||
Depreciation and amortization |
13.6 |
12.6 |
13.3 |
11.9 |
51.4 |
|||||||||||||||
Depreciation in impairment and |
0.2 |
0.9 |
1.3 |
0.8 |
3.2 |
|||||||||||||||
Income taxes |
(1.2) |
8.0 |
2.9 |
(9.7) |
0.0 |
|||||||||||||||
(Income) loss from discontinued |
(2.7) |
(0.1) |
(2.3) |
1.4 |
(3.7) |
|||||||||||||||
EBITDA |
38.6 |
51.7 |
51.1 |
38.8 |
180.2 |
|||||||||||||||
Unusual items impacting net income |
||||||||||||||||||||
Impairment, restructuring and plant |
4.3 |
7.2 |
3.5 |
5.4 |
20.4 |
|||||||||||||||
Non-cash LIFO expense (benefit) |
1.0 |
2.6 |
1.2 |
(0.4) |
4.4 |
|||||||||||||||
Mark-to-market commodity hedging |
(3.1) |
1.8 |
1.3 |
(3.9) |
(3.9) |
|||||||||||||||
Total adjustments |
2.2 |
11.6 |
6.0 |
1.1 |
20.9 |
|||||||||||||||
Adjusted EBITDA |
$ |
40.8 |
$ |
63.3 |
$ |
57.1 |
$ |
39.9 |
$ |
201.1 |
UNAUDITED RECONCILIATION OF NET INCOME ATTRIBUTABLE TO KOPPERS AND ADJUSTED NET INCOME |
||||||||||||||||||||
(In millions) |
||||||||||||||||||||
Three Months Ended |
Year Ended |
|||||||||||||||||||
2019 |
2019 |
2019 |
2019 |
2019 |
||||||||||||||||
Net income attributable to Koppers |
$ |
11.6 |
$ |
14.7 |
$ |
19.8 |
$ |
20.6 |
$ |
66.6 |
||||||||||
Unusual items impacting net income |
||||||||||||||||||||
Impairment, restructuring and plant |
5.9 |
8.4 |
5.9 |
5.0 |
25.3 |
|||||||||||||||
Non-cash LIFO expense (benefit) |
1.1 |
2.7 |
1.2 |
(0.4) |
4.5 |
|||||||||||||||
Mark-to-market commodity hedging |
(3.1) |
1.9 |
1.3 |
(3.9) |
(4.0) |
|||||||||||||||
Total adjustments |
3.9 |
13.0 |
8.4 |
0.7 |
25.8 |
|||||||||||||||
Adjustments to income tax and noncontrolling |
||||||||||||||||||||
Income tax on adjustments to pre-tax |
(2.3) |
(3.2) |
(2.1) |
(15.1) |
(22.7) |
|||||||||||||||
Noncontrolling interests |
0.9 |
(0.3) |
0.6 |
(0.4) |
0.8 |
|||||||||||||||
Effect on adjusted net income |
2.5 |
9.5 |
6.9 |
(14.8) |
3.9 |
|||||||||||||||
Adjusted net income including discontinued |
14.1 |
24.2 |
26.7 |
5.8 |
70.5 |
|||||||||||||||
(Income) loss from discontinued operations |
(2.7) |
(0.1) |
(2.3) |
1.4 |
(3.7) |
|||||||||||||||
Adjusted net income attributable to Koppers |
$ |
11.4 |
$ |
24.1 |
$ |
24.4 |
$ |
7.2 |
$ |
66.8 |
UNAUDITED RECONCILIATION OF DILUTED EARNINGS PER SHARE AND |
||||||||||||||||||||
ADJUSTED EARNINGS PER SHARE |
||||||||||||||||||||
(In millions except share amounts) |
||||||||||||||||||||
Three Months Ended |
Year Ended |
|||||||||||||||||||
2019 |
2019 |
2019 |
2019 |
2019 |
||||||||||||||||
Net income attributable to Koppers |
$ |
11.6 |
$ |
14.7 |
$ |
19.8 |
$ |
20.6 |
$ |
66.6 |
||||||||||
Adjusted net income attributable to Koppers |
$ |
11.4 |
$ |
24.1 |
$ |
24.4 |
$ |
7.2 |
$ |
66.8 |
||||||||||
Denominator for diluted earnings per share (in thousands) |
20,881 |
21,044 |
21,030 |
21,369 |
21,068 |
|||||||||||||||
Earnings per share: |
||||||||||||||||||||
Diluted earnings per share |
$ |
0.55 |
$ |
0.70 |
$ |
0.94 |
$ |
0.96 |
$ |
3.16 |
||||||||||
Adjusted earnings per share |
$ |
0.54 |
$ |
1.14 |
$ |
1.16 |
$ |
0.34 |
$ |
3.18 |
For Information: |
|
|
412 227 2231 |
||
View original content to download multimedia:http://www.prnewswire.com/news-releases/koppers-holdings-inc-provides-first-in-a-series-of-monthly-updates-301062563.html
SOURCE Koppers